KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Healthpeak Properties (DOC) Depreciation & Amortization (IS) (2016 - 2026)

Healthpeak Properties has reported Depreciation & Amortization (IS) over the past 17 years, most recently at $262.1 million for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) fell 4.51% to $262.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, changed 0.16% year-over-year, with the annual reading at $1.1 billion for FY2025, 0.16% changed from the prior year.
  • Depreciation & Amortization (IS) was $262.1 million for Q4 2025 at Healthpeak Properties, roughly flat from $262.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization (IS) peaked at $283.5 million in Q2 2024 and troughed at $157.5 million in Q1 2021.
  • The 5-year median for Depreciation & Amortization (IS) is $186.6 million (2023), against an average of $213.0 million.
  • Year-over-year, Depreciation & Amortization (IS) surged 51.72% in 2024 and then dropped 6.32% in 2025.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $178.1 million in 2021, then grew by 0.59% to $179.2 million in 2022, then grew by 5.24% to $188.5 million in 2023, then skyrocketed by 45.57% to $274.5 million in 2024, then decreased by 4.51% to $262.1 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Depreciation & Amortization (IS) are $262.1 million (Q4 2025), $262.3 million (Q3 2025), and $265.9 million (Q2 2025).